Related Experiment Video
Updated: Feb 6, 2026

Author Spotlight: Advancing Syphilis Research — Innovations in Treponema pallidum Cultivation and Genetic Engineering
Published on: January 24, 2025
Gene subtype analysis of Treponema pallidum for drug resistance to azithromycin
Yuecui Li1, Jin Li1, Weiyue Hu1
1Department of Infectious Diseases, The First People's Hospital of Yongkang, Yongkang, Zhejiang 321300, P.R. China.
Abstract:
Azithromycin has been widely used for the treatment of Treponema pallidum. However, the drug resistance of T. pallidum for azithromycin is currently increasing. The aim of the present study was to analyze the association between gene subtypes of T. pallidum and drug resistance for azithromycin. The gene subtypes of T. pallidum were assayed by a polymerase chain reaction technique. Drug resistance of T. pallidum was analyzed using an antimicrobial susceptibility test. The results demonstrated that gene type tpr presented higher drug resistance compared with arp and tp0548 gene types of T. pallidum. Gene type tpr was identified as eight gene subtypes (14a/f, 14e/f, 12e/f, 12d/f, 6d/f, 11d/f, 14j/f and 8d/f) among 324 cases. It was identified that 23S rRNA A2058G mutation was observed in gene subtypes 14a/f, 14e/f and 12e/f. A2059G mutation occurred in the gene subtypes 8d/f, 12d/f, 6d/f, 11d/f and 14j/f. The proportions of azithromycin-resistant genotypes harboring either the A2058G or the A2059G mutation among the T. pallidum strains were 34.2 and 65.8%, respectively. The antimicrobial susceptibility test demonstrated that A2059G mutations exhibited a higher drug resistance for azithromycin compared with A2058G mutations. In conclusion, these results indicate that azithromycin resistance in T. pallidum is associated with gene subtype, which may contribute to the treatment of T. pallidum.
Insights
Azithromycin resistance in Treponema pallidum is increasing. This study links specific gene subtypes, particularly the tpr type, to higher resistance, with A2059G mutations showing greater impact than A2058G mutations.
Area of Science:
- Microbiology
- Genetics
- Pharmacology
Background:
- Azithromycin is a key treatment for Treponema pallidum infections.
- Increasing azithromycin resistance in T. pallidum poses a significant public health challenge.
- Understanding the genetic basis of this resistance is crucial for effective treatment strategies.
Purpose of the Study:
- To investigate the association between Treponema pallidum gene subtypes and azithromycin resistance.
- To identify specific genetic mutations conferring resistance to azithromycin in T. pallidum.
- To compare the level of drug resistance associated with different gene types and mutations.
Main Methods:
- Polymerase chain reaction (PCR) was used to determine T. pallidum gene subtypes.
- Antimicrobial susceptibility testing was performed to assess drug resistance.
- Genotyping focused on identifying mutations in 23S rRNA, specifically A2058G and A2059G.
Main Results:
- The tpr gene type was associated with higher azithromycin resistance compared to arp and tp0548.
- Specific tpr subtypes (14a/f, 14e/f, 12e/f) harbored the A2058G mutation.
- Other tpr subtypes (8d/f, 12d/f, 6d/f, 11d/f, 14j/f) showed the A2059G mutation.
- A2059G mutations (65.8% of resistant strains) conferred higher resistance than A2058G mutations (34.2% of resistant strains).
Conclusions:
- Azithromycin resistance in Treponema pallidum is significantly associated with specific gene subtypes.
- The A2059G mutation in 23S rRNA is a key driver of high-level azithromycin resistance.
- These findings are vital for guiding future treatment protocols for T. pallidum infections.
More Related Videos
Related Concept Videos
Therapeutic Drug Monitoring: Drug Analysis Methods
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Resistivity
Resistance
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

